Literature DB >> 26249353

Three-dimensional structure of the human breast cancer resistance protein (BCRP/ABCG2) in an inward-facing conformation.

Mark F Rosenberg1, Zsolt Bikadi2, Eszter Hazai1, Tobias Starborg1, Lawrence Kelley3, Naomi E Chayen4, Robert C Ford1, Qingcheng Mao5.   

Abstract

ABCG2 is an efflux drug transporter that plays an important role in drug resistance and drug disposition. In this study, the first three-dimensional structure of human full-length ABCG2 analysed by electron crystallography from two-dimensional crystals in the absence of nucleotides and transported substrates is reported at 2 nm resolution. In this state, ABCG2 forms a symmetric homodimer with a noncrystallographic twofold axis perpendicular to the two-dimensional crystal plane, as confirmed by subtomogram averaging. This configuration suggests an inward-facing configuration similar to murine ABCB1, with the nucleotide-binding domains (NBDs) widely separated from each other. In the three-dimensional map, densities representing the long cytoplasmic extensions from the transmembrane domains that connect the NBDs are clearly visible. The structural data have allowed the atomic model of ABCG2 to be refined, in which the two arms of the V-shaped ABCG2 homodimeric complex are in a more closed and narrower conformation. The structural data and the refined model of ABCG2 are compatible with the biochemical analysis of the previously published mutagenesis studies, providing novel insight into the structure and function of the transporter.

Entities:  

Keywords:  ABC transporter; ABCG2; ATP-binding cassette transporter; BCRP; cryo-electron microscopy; three-dimensional structure from two-dimensional crystals

Mesh:

Substances:

Year:  2015        PMID: 26249353      PMCID: PMC4528803          DOI: 10.1107/S1399004715010676

Source DB:  PubMed          Journal:  Acta Crystallogr D Biol Crystallogr        ISSN: 0907-4449


  61 in total

Review 1.  Electron crystallography of biomolecules: mysterious membranes and missing cones.

Authors:  Robert C Ford; Andreas Holzenburg
Journal:  Trends Biochem Sci       Date:  2007-11-28       Impact factor: 13.807

2.  2dx_merge: data management and merging for 2D crystal images.

Authors:  Bryant Gipson; Xiangyan Zeng; Henning Stahlberg
Journal:  J Struct Biol       Date:  2007-09-25       Impact factor: 2.867

3.  Protein structure prediction on the Web: a case study using the Phyre server.

Authors:  Lawrence A Kelley; Michael J E Sternberg
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

Review 4.  Membrane transporters in drug development.

Authors:  Kathleen M Giacomini; Shiew-Mei Huang; Donald J Tweedie; Leslie Z Benet; Kim L R Brouwer; Xiaoyan Chu; Amber Dahlin; Raymond Evers; Volker Fischer; Kathleen M Hillgren; Keith A Hoffmaster; Toshihisa Ishikawa; Dietrich Keppler; Richard B Kim; Caroline A Lee; Mikko Niemi; Joseph W Polli; Yuichi Sugiyama; Peter W Swaan; Joseph A Ware; Stephen H Wright; Sook Wah Yee; Maciej J Zamek-Gliszczynski; Lei Zhang
Journal:  Nat Rev Drug Discov       Date:  2010-03       Impact factor: 84.694

Review 5.  Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance.

Authors:  Karthika Natarajan; Yi Xie; Maria R Baer; Douglas D Ross
Journal:  Biochem Pharmacol       Date:  2012-01-11       Impact factor: 5.858

6.  The correlation averaging of a regularly arranged bacterial cell envelope protein.

Authors:  W O Saxton; W Baumeister
Journal:  J Microsc       Date:  1982-08       Impact factor: 1.758

Review 7.  Drug efflux transporters and multidrug resistance in acute leukemia: therapeutic impact and novel approaches to mediation.

Authors:  Cindy Q Xia; Peter G Smith
Journal:  Mol Pharmacol       Date:  2012-07-23       Impact factor: 4.436

8.  Pharmacogenetic profiling across the irinotecan pathway in Asian patients with cancer.

Authors:  Qingyu Zhou; Alex Sparreboom; Eng-Huat Tan; Yin-Bun Cheung; Ann Lee; Donald Poon; Edmund J D Lee; Balram Chowbay
Journal:  Br J Clin Pharmacol       Date:  2005-04       Impact factor: 4.335

9.  Conformational cycle of the ABC transporter MsbA in liposomes: detailed analysis using double electron-electron resonance spectroscopy.

Authors:  Ping Zou; Marco Bortolus; Hassane S McHaourab
Journal:  J Mol Biol       Date:  2009-08-26       Impact factor: 5.469

10.  Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout.

Authors:  Owen M Woodward; Anna Köttgen; Josef Coresh; Eric Boerwinkle; William B Guggino; Michael Köttgen
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-08       Impact factor: 11.205

View more
  12 in total

1.  Structure of the human multidrug transporter ABCG2.

Authors:  Nicholas M I Taylor; Ioannis Manolaridis; Scott M Jackson; Julia Kowal; Henning Stahlberg; Kaspar P Locher
Journal:  Nature       Date:  2017-05-29       Impact factor: 49.962

Review 2.  ABC transporter superfamily. An updated overview, relevance in cancer multidrug resistance and perspectives with personalized medicine.

Authors:  Pérez-De Marcos Juan-Carlos; Pérez-Pineda Perla-Lidia; Méndez-Morales Stephanie-Talia; Arellano-Mendoza Mónica-Griselda; Torres-Espíndola Luz-María
Journal:  Mol Biol Rep       Date:  2021-02-22       Impact factor: 2.316

Review 3.  PharmGKB summary: very important pharmacogene information for ABCG2.

Authors:  Alison E Fohner; Deanna J Brackman; Kathleen M Giacomini; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2017-11       Impact factor: 2.089

Review 4.  Multidrug Resistance in Mammals and Fungi-From MDR to PDR: A Rocky Road from Atomic Structures to Transport Mechanisms.

Authors:  Narakorn Khunweeraphong; Karl Kuchler
Journal:  Int J Mol Sci       Date:  2021-04-30       Impact factor: 5.923

5.  The structure of the human ABC transporter ABCG2 reveals a novel mechanism for drug extrusion.

Authors:  Narakorn Khunweeraphong; Thomas Stockner; Karl Kuchler
Journal:  Sci Rep       Date:  2017-10-23       Impact factor: 4.379

6.  Enhancing Drug Efficacy and Therapeutic Index through Cheminformatics-Based Selection of Small Molecule Binary Weapons That Improve Transporter-Mediated Targeting: A Cytotoxicity System Based on Gemcitabine.

Authors:  Justine M Grixti; Steve O'Hagan; Philip J Day; Douglas B Kell
Journal:  Front Pharmacol       Date:  2017-03-27       Impact factor: 5.810

7.  Residues contributing to drug transport by ABCG2 are localised to multiple drug-binding pockets.

Authors:  Megan H Cox; Parth Kapoor; Deborah A Briggs; Ian D Kerr
Journal:  Biochem J       Date:  2018-05-04       Impact factor: 3.857

8.  Structure-function relationships in ABCG2: insights from molecular dynamics simulations and molecular docking studies.

Authors:  Ricardo J Ferreira; Cátia A Bonito; M Natália D S Cordeiro; Maria-José U Ferreira; Daniel J V A Dos Santos
Journal:  Sci Rep       Date:  2017-11-14       Impact factor: 4.379

Review 9.  3D structure of the transporter ABCG2-What's new?

Authors:  Robert Eckenstaler; Ralf A Benndorf
Journal:  Br J Pharmacol       Date:  2020-02-11       Impact factor: 8.739

Review 10.  The multidrug transporter ABCG2: still more questions than answers.

Authors:  Aaron J Horsey; Megan H Cox; Sunehera Sarwat; Ian D Kerr
Journal:  Biochem Soc Trans       Date:  2016-06-15       Impact factor: 5.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.